Moderna (MRNA) Net Income Growth (3y) (2020 - 2026)
Moderna (MRNA) Net Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn | -166.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.84% |
| Dec 31, 2025 | -36.87% |
| Sep 30, 2025 | -29.90% |
| Jun 30, 2025 | -33.43% |
| Mar 31, 2025 | -31.34% |
| Dec 31, 2024 | -30.65% |
| Sep 30, 2024 | -84.26% |
| Jun 30, 2024 | -34.99% |
| Mar 31, 2024 | -43.62% |
| Dec 31, 2023 | 40.86% |
| Sep 30, 2023 | -149.76% |
| Jun 30, 2023 | -127.63% |
| Mar 31, 2023 | 38.16% |
| Dec 31, 2022 | 140.35% |
| Sep 30, 2022 | 118.73% |
| Jun 30, 2022 | 163.43% |
| Mar 31, 2022 | 209.28% |
| Dec 31, 2021 | 231.47% |
| Sep 30, 2021 | 251.67% |
| Jun 30, 2021 | 219.73% |